logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12054497 B1

PDFFull Text
Date of Patent:
Aug. 06, 2024

Filed:

Oct. 28, 2020

Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereof

Applicants:

Genfleet Therapeutics (Shanghai) Inc., Shanghai, CN;

Zhejiang Genfleet Therapeutics Co., Ltd., Shaoxing, CN;

Inventors:

Fusheng Zhou, Shanghai, CN;

Tao Jiang, Shanghai, CN;

Chonglan Lin, Shanghai, CN;

Lijian Cai, Shanghai, CN;

Wan He, Shanghai, CN;

Jiong Lan, Shanghai, CN;

Assignees:

Genfleet Therapeutics (Shanghai)Inc., Shanghai, CN;

Zhejiang Genfleet Therapeutics Co., Ltd., Shaoxing, CN;

Attorney:

Morrison & Foerster LLP

Primary Examiner:

Brenda L Coleman

Int. Cl.
CPC ...
C07D 471/22 (2006.01); A61K 31/4985 (2006.01); A61K 31/5383 (2006.01); A61K 31/55 (2006.01); A61P 35/00 (2006.01); C07D 471/14 (2006.01); C07D 471/16 (2006.01); C07D 498/22 (2006.01);
U.S. Cl.
CPC ...
C07D 498/22 (2013.01); C07D 471/16 (2013.01); C07D 471/22 (2013.01);
Abstract

A substituted heterocyclic fused cyclic compound as represented by formula (I) or formula (IA) and having a selective inhibitory effect on KRAS gene mutation, or a pharmaceutically-acceptable salt, a stereoisomer, a solvate or a prodrug thereof, a pharmaceutical composition containing the compound, and an application thereof in preparation of cancer drugs are provided.

Find Patent Forward Citations

Zhou, Fusheng. (2024). Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereof (U.S. Patent No. 12054497). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12054497

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…